Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 May;59(5):338–341. doi: 10.1136/ard.59.5.338

The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence

K Ho 1, P Chen 1, C Chang 1, F Lu 1
PMCID: PMC1753144  PMID: 10784514

Abstract

OBJECTIVE—Superoxide anion radicals within the human body are regarded as a major cause of inflammation. However, their role in the pathogenesis of ankylosing spondylitis (AS) has not been well identified. This study aimed at investigating the relation between AS and the oxidative metabolism of phagocytes in whole blood.
METHODS—24 patients with classic AS were examined to determine their clinical status; complete blood count, erythrocyte sedimentation rate (ESR), and C reactive protein (CRP) were determined, and levels of the superoxide anion radicals in the patients with AS and 21 healthy subjects were assessed by the ultraweak chemiluminescence method. Subsequently, the relation between this disease and phagocytes was examined by using N-formyl-methionyl-leucyl-phenylalanine (fMLP) and phorbol-12-myristate-13-acetate (PMA) stimulants.
RESULTS—In clinical assessments, patients with AS had abnormally raised serum CRP (>10 mg/l) and ESR (>15 mm/1st h) levels. In contrast with healthy subjects, patients with AS had significantly increased rates of superoxide anion radical production in their whole blood either in the resting state or with either fMLP or PMA stimulation. In addition, chemiluminescence maximum light intensity was significantly higher in patients with AS than in healthy subjects after fMLP or PMA stimulation.
CONCLUSIONS—Our results suggest that the phagocytes of patients with AS are partly activated in the resting state, and are sensitive to fMLP or PMA stimulation. The priming of phagocytes in the bloodstream is likely to be a causative factor in the onset of AS.



Full Text

The Full Text of this article is available as a PDF (127.2 KB).

Figure 1  .

Figure 1  

Open in a new tab

Comparisons of superoxide anion radicals in whole blood between one patient with AS and one healthy subject using the lucigenin enhanced ultraweak chemiluminescence method. 0.2 ml of heparinised blood was mixed with 0.1 ml of phosphate buffered saline (pH 7.4), N-formyl-methionyl-leucyl-phenylalanine (fMLP; 1 × 10−5 mol/l) or phorbol-12-myristate-13-acetate (PMA; 10 µg/ml) at 37°C. Then, 1 ml lucigenin (0.01 mmol/l) was added 200 seconds later. The levels of superoxide anion radicals in one patient with AS and one healthy subject were assessed by the ultraweak chemiluminescence method. (1) AS + PMA; (2) AS + fMLP; (3) healthy subject + PMA; (4) healthy subject + fMLP; (5) AS only; (6) healthy subject only.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biasi D., Carletto A., Caramaschi P., Bellavite P., Andrioli G., Caraffi M., Pacor M. L., Bambara L. M. Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol. 1995 Sep-Oct;13(5):623–627. [PubMed] [Google Scholar]
  2. Brewerton D. A., Hart F. D., Nicholls A., Caffrey M., James D. C., Sturrock R. D. Ankylosing spondylitis and HL-A 27. Lancet. 1973 Apr 28;1(7809):904–907. doi: 10.1016/s0140-6736(73)91360-3. [DOI] [PubMed] [Google Scholar]
  3. Cunnane G., Bresnihan B., FitzGerald O. Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum. 1998 Jan;41(1):180–182. doi: 10.1002/1529-0131(199801)41:1<180::AID-ART24>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  4. Gratacós J., Collado A., Filella X., Sanmartí R., Cañete J., Llena J., Molina R., Ballesta A., Muñoz-Gómez J. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol. 1994 Oct;33(10):927–931. doi: 10.1093/rheumatology/33.10.927. [DOI] [PubMed] [Google Scholar]
  5. Lu F. J., Lin J. T., Wang H. P., Huang W. C. A simple, sensitive, non-stimulated photon counting system for detection of superoxide anion in whole blood. Experientia. 1996 Feb 15;52(2):141–144. doi: 10.1007/BF01923359. [DOI] [PubMed] [Google Scholar]
  6. Miller C., Russell A. S. The generation of superoxide anions by polymorphonuclear leucocytes from patients with ankylosing spondylitis in response to the stimulant f-met-leu-phe. Clin Exp Rheumatol. 1986 Apr-Jun;4(2):135–137. [PubMed] [Google Scholar]
  7. Mäki-Ikola O., Hällgren R., Kanerud L., Feltelius N., Knutsson L., Granfors K. Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis. 1997 Jul;56(7):421–425. doi: 10.1136/ard.56.7.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Nurcombe H. L., Bucknall R. C., Edwards S. W. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo. Ann Rheum Dis. 1991 Mar;50(3):147–153. doi: 10.1136/ard.50.3.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Okuyama M., Sakon M., Kambayashi J., Kawasaki T., Monden M. Involvement of protein phosphatase 2A in PKC-independent pathway of neutrophil superoxide generation by fMLP. J Cell Biochem. 1996 Feb;60(2):279–288. doi: 10.1002/(sici)1097-4644(19960201)60:2<279::aid-jcb12>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  10. Ristola M., Leirisalo-Repo M., Repo H. Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence. Ann Rheum Dis. 1991 Nov;50(11):782–786. doi: 10.1136/ard.50.11.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tiwana H., Walmsley R. S., Wilson C., Yiannakou J. Y., Ciclitira P. J., Wakefield A. J., Ebringer A. Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br J Rheumatol. 1998 May;37(5):525–531. doi: 10.1093/rheumatology/37.5.525. [DOI] [PubMed] [Google Scholar]
  12. Tutuncu Z. N., Bilgie A., Kennedy L. G., Calin A. Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis. 1994 Jun;53(6):425–426. doi: 10.1136/ard.53.6.425-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wendling D., Didier J. M., Vuitton D. A. The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int. 1991;11(4-5):187–189. doi: 10.1007/BF00332560. [DOI] [PubMed] [Google Scholar]
  14. Yu D. T., Choo S. Y., Schaack T. Molecular mimicry in HLA-B27-related arthritis. Ann Intern Med. 1989 Oct 1;111(7):581–591. doi: 10.7326/0003-4819-111-7-581. [DOI] [PubMed] [Google Scholar]
  15. el Abbouyi A., Paul J. L., Roch-Arveiller M., Moachon L., Dougados M., Giroud J. P., Amor B., Raichvarg D. Blood polymorphonuclear behavior in patients with ankylosing spondylitis. Clin Exp Rheumatol. 1988 Oct-Dec;6(4):401–403. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES